Doctor flags unexpected signs of deadly liver disease even non-drinkers must watch out for… as 4 million Britons could soon be screened

Millions of people could soon be offered regular screening for deadly liver disease under new guidelines, amid a terrifying rise in the ‘silent’ killer.
An estimated one in five people in the UK are thought to have early stages of the disease, with diagnoses surging five-fold in a decade.
Yet most have no idea they are even at risk as the condition is notoriously difficult to detect.
Now, the British Society of Gastroenterology has recommended that 4.6 million people in the UK living with type 2 diabetes must undergo regular checks for the condition, as well as those who are overweight with at least one additional risk factor.
Patients would be offered screening every five years, with high risk individuals referred for a FibroScan, a test that can detect scarring in the liver before symptoms develop.
Excess body fat is now driving a large proportion of liver disease cases, as opposed to alcohol.
Experts have welcomed the recommendations but add that patients must also be aware of the red flag warning signs – as many who are vulnerable may not qualify for screening.
Symptoms can include problems easily mistaken for other, less serious conditions like exhaustion, difficulty concentrating and nausea.
MASLD is most common among people who are overweight or those living with type 2 diabetes
‘Most serious liver disease develops over many years,’ Professor Stuart McPherson, a consultant hepatologist and lead author of the national guidelines, said.
‘The challenge is that patients often feel perfectly well until significant scarring has occurred.
‘Deaths from liver disease in the UK have risen more than fourfold over the past four decades, largely driven by harmful alcohol use and the increasing levels of obesity.
‘But opportunities for detection continue to be missed, despite many individuals having clear risk factors.’
The screening programme could help identify thousands of cases that would otherwise go unnoticed.
But an estimated 1.2 million people in the UK are thought to be living with type 2 diabetes without knowing it.
Millions more have prediabetes, a condition marked by elevated blood sugar levels that can significantly increase the risk of developing both diabetes and fatty liver disease.
For these patients, recognising the warning signs of the disease – known medically as metabolic dysfunction-associated steatotic liver disease (MASLD) – could help prompt earlier testing and treatment.
Professor William Alazawi, a hepatologist at Queen Mary University of London, said there is ‘little doctors can do’ to reverse the damage when the disease is spotted late.
He said: ‘We know liver disease is undiagnosed and many people live with it for many years without symptoms.
‘Too many people find out they have it for the first time when they present with liver failure – when there is little we can do to reverse the damage.
‘And a major part of the problem is that if it does cause symptoms in its early stages, they’re often vague and non-specific.’
One of the most common complaints is persistent fatigue, with sufferers often reporting low energy levels and difficulty concentrating.
Others may experience pain or discomfort in the upper right side of the abdomen, where the liver is located, while nausea and loss of appetite can also occur.
However, Prof Alazawi cautioned that these symptoms are not unique to liver disease.
‘Abdominal pain, fatigue and nausea are all non-specific symptoms and not everyone experiencing these problems will have a liver problem,’ he said.
Persistent itching can also be a sign of liver problems.
Known as cholestatic pruritus, it is caused by a build-up of bile acids in the bloodstream when bile does not flow properly through the liver.
It can range from mild to severe and is often felt on the palms of the hands, soles of the feet and over the abdomen.
In more advanced cases, patients may develop jaundice, which causes the skin and whites of the eyes to take on a yellow tinge.
The condition occurs when bilirubin – the yellow pigment produced by the normal breakdown of red blood cells – builds up in the body.
Some patients may also notice their skin appearing unusually pale, greyish or sallow.
In severe cases, liver failure can also trigger confusion and vomiting blood.
But Prof Alazawi said such symptoms are typically signs that serious liver damage has already occurred.
‘Signs of liver failure such as jaundice and abdominal swelling are very late signs,’ he said.
‘The majority of people with chronic liver disease do not have any symptoms, which makes our job quite challenging.
‘That’s why the blood-testing guidance is so important, because we cannot rely on symptoms alone to narrow our patients down.’
The focus on people with type 2 diabetes reflects their substantially higher risk of developing serious liver disease.
‘People with type 2 diabetes are resistant to insulin, which leads to an increased accumulation of fat in the liver,’ Prof Alazawi said.
‘In addition, these people have a higher risk of progressing to scarring in the liver, which is the precursor to liver failure and increases the risk of liver cancer.’
He also stressed that while alcohol remains a major risk factor, it is no longer the sole driver of liver disease.
‘We need to remind people that liver disease is not just due to alcohol,’ he said.
‘There is always a balance with extra testing, but we need to do something to address the fact that liver disease detected at an early stage can change the trajectory of a patient’s life.’
Vanessa Hebditch, Director of Communications and Policy at Liver UK, added: ‘In many cases, finding liver disease early gives people the opportunity to prevent progression and even reverse damage.
‘That is why these recommendations have the potential to transform lives.’
